SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-021146
Filing Date
2022-02-14
Accepted
2022-02-14 06:12:44
Documents
1
Group Members
CITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES GROUP LPCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 BOLT BIOTHERAPEUTICS, INC. tm222598d7_sc13ga.htm SC 13G/A 138137
  Complete submission text file 0001104659-22-021146.txt   139928
Mailing Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603 312-395-2100
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Subject) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92160 | Film No.: 22624601
SIC: 2834 Pharmaceutical Preparations